Explore how sono-synthesized triazole derivatives conjugated with selenium nanoparticles are revolutionizing cancer treatment through targeted, non-invasive therapy.
Exploring the development of benzimidazole-1,2,3-triazole hybrid molecules as multi-target cancer therapies that overcome drug resistance.
Exploring the potential of benzofuran-quinoline hybrids as multi-target anticancer agents with antiproliferative and DNA cleavage capabilities.
Explore how copper isotopes 64Cu and 67Cu are revolutionizing pretargeted radioimmunotherapy for precise cancer treatment with minimal side effects.
Discover how antibody-targeted steroids are revolutionizing cancer treatment by delivering precise steroid therapy while minimizing side effects.
Discover how scientists use orthogonal double-click chemistry to track platinum-based anticancer agents inside cancer cells, revolutionizing targeted cancer treatment.